Showing results (1341-1350 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|February 5, 2024
Radiation-induced coronary artery disease during immune checkpoint inhibitor therapy: a case reportXiajing Qian, Kequan Ding, Yi LuImmunotherapy|February 6, 2024
Summary of certolizumab pegol in psoriasis including structural features, pharmacokinetics and treatmentMichio Tokuyama, Tomotaka MabuchiImmunotherapy|March 21, 2024
The role of ixekizumab in the treatment of nonradiographic axial spondyloarthritisBora Nam, Tae-Hwan KimImmunotherapy|March 20, 2024
Pembrolizumab in patients from China with microsatellite instability-high/mismatch repair deficient tumors: KEYNOTE-158Jianming Xu, Yimin Mao, Nong Xu, et al.Immunotherapy|August 1, 2023
Successful treatment with carboplatin and paclitaxel in melanoma progression after immune-related adverse eventsÖzgecan Dülgar, Aditi Saha, Kelly M Elleson, et al.Immunotherapy|April 17, 2024
Positioning risankizumab in the treatment algorithm of moderate-to-severe Crohn's diseaseFrancesca Lusetti, Ferdinando D'Amico, Mariangela Allocca, et al.Immunotherapy|September 4, 2023
Tumor lysis syndrome induced by tebentafuspTheresa Ruf, Anna Leonhardt, David Anz, et al.Immunotherapy|September 11, 2023
Modification of allergen subcutaneous immunotherapy safety precautions and systemic allergic reaction rate reductionKeren Mahlab-Guri, David Mishayev, Marina Yakovlev, et al.Immunotherapy|September 11, 2023
Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settingsKe Zu, Ashwini Arunachalam, Andriana Hohlbauch, et al.Immunotherapy|May 27, 2026
Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosisTablo Ahmed Merza Mohammed, Teshk Nouri Shawis, Talar Ahmad Merza Mohammad, et al.Pageof 188